{"title":"HIV test coverage among pregnant women in Ethiopia: A systematic review and meta-analysis.","authors":"Aklilu Endalamaw, Demeke Geremew, Sisay Mulugeta Alemu, Sintayehu Ambachew, Hiwot Tesera, Tesfa Dejenie Habtewold","doi":"10.2989/16085906.2021.1980066","DOIUrl":null,"url":null,"abstract":"<p><p><i>Introduction</i>: A human immunodeficiency virus (HIV) test during pregnancy is the gateway to the prevention of mother-to-child transmission (PMTCT) of HIV. Estimating the national uptake of HIV tests among pregnant women is an important course of action. Thus, we pooled the information about the national uptake of HIV tests and determined the significant factors among pregnant women in Ethiopia.<i>Methods</i>: We searched PubMed, Scopus, Web of Science, and Google Scholar databases. We also searched for cross-references to get additional relevant studies, and included cross-sectional, case-control and cohort study studies. We applied a random-effects model meta-analysis to pool the national data of uptake of HIV tests. Galbraith's plot and Egger's regression test were employed to check publication bias, and heterogeneity was assessed using <i>I </i>² statistics. The protocol registered is found in the PROSPERO database with the registration number CRD42019129166.<i>Results</i>: In total, 22 articles with 13 818 pregnant women study participants were involved. The national uptake of HIV tests among pregnant women was 79.6% (95% CI 73.9-85.4). Living in urban areas (AOR 2.8; 95% CI 1.1-4.6), previous HIV tests (AOR 4.6; 95% CI 1.2-8.0), and comprehensive knowledge on mother-to-child transmission (MTCT) (AOR 2.61; 95% CI 1.5-3.7) and PMTCT of HIV (AOR 2.1; 95% CI 1.5-2.8) were associated with increased practice of HIV tests.<i>Conclusion</i>: This review showed that HIV test coverage among pregnant women was approximately 80% and substantially lower than the national recommendation. Addressing HIV-related health services for rural women and providing health information on MTCT and PMTCT of HIV to increase HIV testing coverage is required.</p>","PeriodicalId":520548,"journal":{"name":"African journal of AIDS research : AJAR","volume":" ","pages":"259-269"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"African journal of AIDS research : AJAR","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2989/16085906.2021.1980066","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Introduction: A human immunodeficiency virus (HIV) test during pregnancy is the gateway to the prevention of mother-to-child transmission (PMTCT) of HIV. Estimating the national uptake of HIV tests among pregnant women is an important course of action. Thus, we pooled the information about the national uptake of HIV tests and determined the significant factors among pregnant women in Ethiopia.Methods: We searched PubMed, Scopus, Web of Science, and Google Scholar databases. We also searched for cross-references to get additional relevant studies, and included cross-sectional, case-control and cohort study studies. We applied a random-effects model meta-analysis to pool the national data of uptake of HIV tests. Galbraith's plot and Egger's regression test were employed to check publication bias, and heterogeneity was assessed using I ² statistics. The protocol registered is found in the PROSPERO database with the registration number CRD42019129166.Results: In total, 22 articles with 13 818 pregnant women study participants were involved. The national uptake of HIV tests among pregnant women was 79.6% (95% CI 73.9-85.4). Living in urban areas (AOR 2.8; 95% CI 1.1-4.6), previous HIV tests (AOR 4.6; 95% CI 1.2-8.0), and comprehensive knowledge on mother-to-child transmission (MTCT) (AOR 2.61; 95% CI 1.5-3.7) and PMTCT of HIV (AOR 2.1; 95% CI 1.5-2.8) were associated with increased practice of HIV tests.Conclusion: This review showed that HIV test coverage among pregnant women was approximately 80% and substantially lower than the national recommendation. Addressing HIV-related health services for rural women and providing health information on MTCT and PMTCT of HIV to increase HIV testing coverage is required.
在怀孕期间进行人类免疫缺陷病毒(HIV)检测是预防艾滋病毒母婴传播(PMTCT)的门户。估计全国孕妇接受艾滋病毒检测的情况是一项重要的行动方针。因此,我们汇集了有关全国艾滋病毒检测的信息,并确定了埃塞俄比亚孕妇中的重要因素。方法:检索PubMed、Scopus、Web of Science、Google Scholar等数据库。我们还检索了交叉参考文献以获得更多相关研究,包括横断面、病例对照和队列研究。我们采用随机效应模型荟萃分析汇集了全国艾滋病毒检测的数据。采用Galbraith图和Egger回归检验检验发表偏倚,采用I²统计量评价异质性。注册的协议可以在PROSPERO数据库中找到,注册号为CRD42019129166。结果:共纳入22篇文献,13 818名孕妇参与研究。全国孕妇接受艾滋病毒检测的比例为79.6% (95% CI 73.9-85.4)。生活在城市地区(AOR 2.8;95% CI 1.1-4.6),既往HIV检测(AOR 4.6;95% CI 1.2-8.0),以及关于母婴传播(MTCT)的全面知识(AOR 2.61;95% CI 1.5-3.7)和PMTCT (AOR 2.1;95% CI 1.5-2.8)与艾滋病毒检测的增加有关。结论:本综述显示,孕妇的艾滋病毒检测覆盖率约为80%,大大低于国家建议。必须为农村妇女提供与艾滋病毒有关的保健服务,并提供关于母婴传播和预防母婴传播艾滋病毒的保健信息,以增加艾滋病毒检测的覆盖率。